Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-C Ronald Kahn Researcher Activity Profile

Research Author Detailed Information 

profile photo of C Ronald KahnC Ronald kahn researcher

C Ronald Kahn Publication Rate By Year

C Ronald Kahn has published 1 paper(s) in 1981, 1 paper(s) in 2003, 1 paper(s) in 2006, 22 paper(s) in 2007, 2 paper(s) in 2008, for a total of 27 research publications in total.

C Ronald Cr Kahn Author Information

LAST NAME: kahn

FIRST NAME: C Ronald

INITIALS: cr

AFFILIATION:

Papers

C Ronald Kahn's Publication Record

  1. Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Year Published: 2006
  2. Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-8655, Japan.
  3. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Year Published: 2007
  4. Joslin Diabetes Center, Boston, MA 02215, USA. c.ronald.kahn@joslin.harvard.edu
  5. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Year Published: 2007
  6. Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  7. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Year Published: 2007
  8. Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA.
  9. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Year Published: 2007
  10. Department of Cellular and Molecular Physiology, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  11. TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity. Year Published: 2007
  12. Section on Obesity and Hormone Action, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  13. Developmental origin of fat: tracking obesity to its source. Year Published: 2007
  14. Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  15. IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance. Year Published: 2007
  16. Department of Metabolic Medicine, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
  17. Mitochondrial proton leak in obesity-resistant and obesity-prone mice. Year Published: 2007
  18. University of Iowa, Iowa City Veterans Affairs Medical Center, Iowa City, IA 52242, USA.
  19. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Year Published: 2007
  20. Institute of Molecular Biotechnology of the Austrian Academy of Science, Dr Bohrgasse 3, 1030, Vienna, Austria.
  21. Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Year Published: 2007
  22. Joslin Diabetes Center, One Joslin Place and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  23. A patient with type B insulin resistance syndrome, responsive to immune therapy. Year Published: 2007
  24. KA Page is a Clinical Endocrinology Fellow, KC Herold is a Professor of Immunology and SE Inzucchi is a Professor of Medicine, at the Yale School of Medicine, New Haven, CT, USA.
  25. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. Year Published: 2003
  26. MRC Protein Phosphorylation Unit, School of Life Sciences, MSI/WTB Complex, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
  27. A patient with type B insulin resistance syndrome, responsive to immune therapy. Year Published: 2007
  28. Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520-8020, USA. kathleen.page@yale.edu
  29. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Year Published: 2007
  30. Institute of Molecular Biotechnology of the Austrian Academy of Science, Dr Bohrgasse 3, 1030, Vienna, Austria.
  31. Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Year Published: 2007
  32. Joslin Diabetes Center, One Joslin Place and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  33. Rad GTPase deficiency leads to cardiac hypertrophy. Year Published: 2007
  34. Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.
  35. Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Year Published: 2007
  36. Joslin Diabetes Center, One Joslin Place and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  37. Mitochondrial proton leak in obesity-resistant and obesity-prone mice. Year Published: 2007
  38. University of Iowa, Iowa City Veterans Affairs Medical Center, Iowa City, IA 52242, USA.
  39. Developmental origin of fat: tracking obesity to its source. Year Published: 2007
  40. Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  41. Rad GTPase deficiency leads to cardiac hypertrophy. Year Published: 2007
  42. Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.
  43. TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity. Year Published: 2007
  44. Section on Obesity and Hormone Action, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  45. IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance. Year Published: 2007
  46. Department of Metabolic Medicine, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
  47. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Year Published: 2008
  48. Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
  49. A patient with type B insulin resistance syndrome, responsive to immune therapy. Year Published: 2007
  50. Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520-8020, USA. kathleen.page@yale.edu
  51. Circumscribing or periadenomal vessel: a helpful angiographic finding in certain islet cell and parathyroid adenomas. Year Published: 1981
  52. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Year Published: 2008
  53. Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News